Wu S - Search Results

1

Single-cell transcriptomics highlights immunological dysregulations of monocytes in the pathobiology of COPD.

Huang Q, Wang Y, Zhang L, Qian W, Shen S, Wang J, Wu S, Xu W, Chen B, Lin M, Wu J. Huang Q, et al. Among authors: wu s, wu j. Respir Res. 2022 Dec 20;23(1):367. doi: 10.1186/s12931-022-02293-2. Respir Res. 2022. PMID: 36539833 Free PMC article.

2

Down-regulation of ALKBH2 increases cisplatin sensitivity in H1299 lung cancer cells.

Wu SS, Xu W, Liu S, Chen B, Wang XL, Wang Y, Liu SF, Wu JQ. Wu SS, et al. Among authors: wu jq. Acta Pharmacol Sin. 2011 Mar;32(3):393-8. doi: 10.1038/aps.2010.216. Epub 2011 Jan 31. Acta Pharmacol Sin. 2011. PMID: 21278781 Free PMC article.

3

Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib.

Xu W, Wei Y, Wu S, Wang Y, Wang Z, Sun Y, Cheng SY, Wu J. Xu W, et al. Among authors: wu s, wu j. Cell Biosci. 2015 Feb 5;5:7. doi: 10.1186/2045-3701-5-7. eCollection 2015. Cell Biosci. 2015. PMID: 25973173 Free PMC article.

4

Genetic Variations in Key MicroRNAs are Associated With the Survival of Nonsmall Cell Lung Cancer.

Wu S, Shen W, Pan Y, Zhu M, Xie K, Geng L, Wang Y, Liang Y, Xu J, Cao S, Xu W, Chen B, Hu Z, Ma H, Wu J, Shen H. Wu S, et al. Among authors: wu j. Medicine (Baltimore). 2015 Nov;94(47):e2084. doi: 10.1097/MD.0000000000002084. Medicine (Baltimore). 2015. PMID: 26632718 Free PMC article.

5

Depleted aldehyde dehydrogenase 1A1 (ALDH1A1) reverses cisplatin resistance of human lung adenocarcinoma cell A549/DDP.

Wei Y, Wu S, Xu W, Liang Y, Li Y, Zhao W, Wu J. Wei Y, et al. Among authors: wu s, wu j. Thorac Cancer. 2017 Jan;8(1):26-32. doi: 10.1111/1759-7714.12400. Epub 2016 Nov 4. Thorac Cancer. 2017. PMID: 27813328 Free PMC article.

6

Per2 participates in AKT-mediated drug resistance in A549/DDP lung adenocarcinoma cells.

Chen B, Tan Y, Liang Y, Li Y, Chen L, Wu S, Xu W, Wang Y, Zhao W, Wu J. Chen B, et al. Among authors: wu s, wu j. Oncol Lett. 2017 Jan;13(1):423-428. doi: 10.3892/ol.2016.5430. Epub 2016 Nov 24. Oncol Lett. 2017. PMID: 28123577 Free PMC article.

7

The miR-608 rs4919510 polymorphism may modify cancer susceptibility based on type.

Wu S, Yuan W, Shen Y, Lu X, Li Y, Tian T, Jiang L, Zhuang X, Wu J, Chu M. Wu S, et al. Among authors: wu j. Tumour Biol. 2017 Jun;39(6):1010428317703819. doi: 10.1177/1010428317703819. Tumour Biol. 2017. PMID: 28653886 Free article.

8

RAGE may act as a tumour suppressor to regulate lung cancer development.

Wu S, Mao L, Li Y, Yin Y, Yuan W, Chen Y, Ren W, Lu X, Li Y, Chen L, Chen B, Xu W, Tian T, Lu Y, Jiang L, Zhuang X, Chu M, Wu J. Wu S, et al. Among authors: wu j. Gene. 2018 Apr 20;651:86-93. doi: 10.1016/j.gene.2018.02.009. Epub 2018 Feb 5. Gene. 2018. PMID: 29421442

9

Functional variant of the carboxypeptidase M (CPM) gene may affect silica-related pneumoconiosis susceptibility by its expression: a multistage case-control study.

Chu M, Wu S, Wang W, Yu Y, Zhang M, Sang L, Tian T, Lu Y, Yuan W, Huang Q, Yi M, Gao Y, Xiao J, Lian Y, Zhuang X, Zhang ZF, Wu J. Chu M, et al. Among authors: wu s, wu j. Occup Environ Med. 2019 Mar;76(3):169-174. doi: 10.1136/oemed-2018-105545. Epub 2019 Jan 23. Occup Environ Med. 2019. PMID: 30674606 Free PMC article.

10

Genetic variations in miR-125 family and the survival of non-small cell lung cancer in Chinese population.

Wu S, Shen W, Yang L, Zhu M, Zhang M, Zong F, Geng L, Wang Y, Huang T, Pan Y, Cao S, Dai J, Ma H, Wu J. Wu S, et al. Among authors: wu j. Cancer Med. 2019 May;8(5):2636-2645. doi: 10.1002/cam4.2073. Epub 2019 Mar 7. Cancer Med. 2019. PMID: 30843663 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37,215 results

Search Page